U.S. FDA approves Mylan generic of Lilly lung cancer drug Alimta
The U.S. Food and Drug Administration on Thursday granted Mylan NV tentative approval for its generic version of Eli Lilly and Co's lung cancer drug Alimta.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Alimta | Cancer | Cancer & Oncology | Food and Drug Administration (FDA) | Health | Lung Cancer